Detalhe da pesquisa
1.
MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231.
Blood
; 143(20): 2053-2058, 2024 May 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38457359
2.
Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma.
N Engl J Med
; 387(18): 1649-1660, 2022 11 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36322844
3.
A gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma.
Blood
; 139(6): 889-893, 2022 02 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34662378
4.
Heat shock factor 1 (HSF1-pSer326) predicts response to bortezomib-containing chemotherapy in pediatric AML: a COG report.
Blood
; 137(8): 1050-1060, 2021 02 25.
Artigo
Inglês
| MEDLINE | ID: mdl-32959058
5.
Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712.
Pediatr Blood Cancer
; 70(12): e30672, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37710306
6.
IL-10 and TNFα are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children's oncology group report.
Pediatr Hematol Oncol
; 40(2): 147-158, 2023 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-35838057
7.
DNA Damage Response-Related Proteins Are Prognostic for Outcome in Both Adult and Pediatric Acute Myelogenous Leukemia Patients: Samples from Adults and from Children Enrolled in a Children's Oncology Group Study.
Int J Mol Sci
; 24(6)2023 Mar 20.
Artigo
Inglês
| MEDLINE | ID: mdl-36982970
8.
Reverse Phase Protein Array Profiling Identifies Recurrent Protein Expression Patterns of DNA Damage-Related Proteins across Acute and Chronic Leukemia: Samples from Adults and the Children's Oncology Group.
Int J Mol Sci
; 24(6)2023 Mar 13.
Artigo
Inglês
| MEDLINE | ID: mdl-36982537
9.
Inhibition of the Sec61 translocon overcomes cytokine-induced glucocorticoid resistance in T-cell acute lymphoblastic leukaemia.
Br J Haematol
; 198(1): 137-141, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35434798
10.
Tumor-associated myeloid cells provide critical support for T-ALL.
Blood
; 136(16): 1837-1850, 2020 10 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32845007
11.
Clinical relevance of proteomic profiling in de novo pediatric acute myeloid leukemia: a Children's Oncology Group study.
Haematologica
; 107(10): 2329-2343, 2022 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35021602
12.
Reverse phase protein arrays in acute leukemia: investigative and methodological challenges.
Expert Rev Proteomics
; 18(12): 1087-1097, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34965151
13.
Extracellular vesicles impose quiescence on residual hematopoietic stem cells in the leukemic niche.
EMBO Rep
; 20(7): e47546, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31267709
14.
The Anti-Tumor Activity of the NEDD8 Inhibitor Pevonedistat in Neuroblastoma.
Int J Mol Sci
; 22(12)2021 Jun 18.
Artigo
Inglês
| MEDLINE | ID: mdl-34207315
15.
Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia.
Blood
; 131(9): 995-999, 2018 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29305553
16.
Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children's Oncology Group.
Haematologica
; 105(7): 1879-1886, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32029509
17.
Bortezomib reinduction chemotherapy in high-risk ALL in first relapse: a report from the Children's Oncology Group.
Br J Haematol
; 186(2): 274-285, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30957229
18.
Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1-2 trial.
Lancet Oncol
; 19(9): 1229-1238, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30122620
19.
Shining a light on cell signaling in leukemia through proteomics: relevance for the clinic.
Expert Rev Proteomics
; 15(7): 613-622, 2018 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29898608
20.
Long-term evidence that a pediatric oncology mentorship program for young investigators is feasible and beneficial in the cooperative group setting: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 65(3)2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29193588